Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients?

Marcello CovinoGiuseppe De MatteisDavide Della PollaMaria Livia BurzoMarco Maria PascaleMichele SantoroRaimondo De CristofaroAntonio GasbarriniErica De CandiaFrancesco Franceschi

Published in: Aging clinical and experimental research (2021)

Among older patients hospitalized for COVID-19, chronic OAC therapy was not associated with a reduced risk of in-hospital death. Moreover, our data suggest similar outcome both for patients on VKAs or in patients on DOACs.

Keyphrases

end stage renal disease
coronavirus disease
sars cov
ejection fraction
newly diagnosed
chronic kidney disease
healthcare
prognostic factors
patient reported outcomes
venous thromboembolism
big data
mesenchymal stem cells
artificial intelligence
data analysis